Try our Advanced Search for more refined results
IN RE ASACOL ANTITRUST LITIGATION
Case Number:
1:15-cv-12730
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Adler Pollock
- Andrews DeValerio
- Berger Montague
- Berman Tabacco
- Day Pitney
- Faruqi & Faruqi
- Foley Hoag
- Garwin Gerstein
- Gustafson Gluek
- Hagens Berman
- Heim Payne
- Hilliard & Shadowen
- Levin Papantonio
- Locke Lord
- Lockridge Grindal
- Mintz Levin
- Odom & Des Roches
- Pugsley Wood
- Smith Segura
- Spector Roseman
- Sperling & Slater
- Taus Cebulash
- Vanek Vickers
- Wagstaff & Cartmell
- Wexler Boley
- Whistleblower Law Collaborative
- White & Case
Companies
- Ahold Delhaize
- Allergan PLC
- American Federation of State County & Municipal Employees
- Rochester Drug Cooperative Inc.
- United Food & Commercial Workers International Union
- Warner Chilcott Limited
- Zydus Pharmaceuticals Inc.
Sectors & Industries:
-
January 25, 2018
Asacol Antitrust Trial Delayed To Let Allergan Appeal Class
The First Circuit on Thursday granted an indefinite delay of an antitrust trial slated to start next week, allowing Allergan PLC to appeal the certification of a class of unions and grocers who claim the company and a subsidiary manipulated the market with a monopolistic hard switch of available anti-inflammatory drugs.
-
January 24, 2018
Allergan Vies For Insurance Coverage Lists In Asacol Trial
Allergan and Warner Chilcott on Tuesday asked a Massachusetts federal court for an order stating that lists of prescription drugs covered by insurers are admissible evidence during an antitrust trial brought by a class of organizations that purchased ulcerative colitis drug Asacol.
-
January 08, 2018
Allergan Fights To Keep Live Testimony In Asacol Trial
Attorneys for Allergan PLC and subsidiary Warner Chilcott Ltd. asked a Massachusetts federal judge on Monday to block a group of unions and grocers from replacing witness testimony with recorded depositions in the antitrust class action set to go to trial in two weeks.
-
December 05, 2017
Buyer Class Fights Allergan Over Causation In Antitrust Row
A class of end purchasers accusing Allergan PLC and its subsidiary Warner Chilcott Ltd. of stifling competition for their ulcerative colitis drugs urged a Massachusetts federal court Monday not to certify a causation issue, saying they've adequately argued that the companies' alleged wrongdoing caused them harm.
-
November 09, 2017
Allergan Can't Nix Antitrust Row As Buyer Class Is Certified
Allergan PLC and several related companies lost their bid to exit an antitrust suit by end purchasers of an ulcerative colitis drug as a Massachusetts federal judge on Thursday denied their attempt to kill the claims and granted certification to a class of buyers.
-
October 06, 2017
Attys Argue For 1/3 Slice Of $15M Asacol Deal Pie As Fees
Attorneys for direct purchasers who recently struck a $15 million deal in a suit accusing Allergan PLC and its subsidiary Warner Chilcott Ltd. of stifling competition for their drug Asacol urged a Massachusetts federal judge Thursday to hand them almost $5.46 million in fees and expenses, arguing that they are asking for significantly less than the $8.3 million worth of work they did in the case.
-
September 19, 2017
Warner Chilcott Seeks Out Of Asacol Antitrust Suit
Allergan subsidiary Warner Chilcott has told a Massachusetts federal court that pulling its Asacol ulcerative colitis drug off the market pursuant to a federal safety order can't be considered anti-competitive conduct, urging the court to grant it a quick win in an antitrust lawsuit.
-
September 15, 2017
Allergan To Pay $15M To End Asacol Antitrust Claims
A Massachusetts federal judge Thursday granted preliminary approval to a $15 million settlement that would end claims brought by direct purchasers accusing Allergan PLC and its subsidiary Warner Chilcott Ltd. of stifling competition for their ulcerative colitis drugs.
-
April 12, 2017
Shire Blasts Allergan's Discovery Bid In Antitrust Suit
Allergan shouldn't be able to get competitor Shire's most sensitive data to beat back antitrust allegations over an ulcerative colitis drug, Shire told a federal court in Massachusetts on Tuesday.
-
February 13, 2017
Buyers Want Patent Suit Docs In Asacol Antitrust Suit
Wholesalers accusing Warner Chilcott of trying to thwart competition for its ulcerative colitis medications asked a Massachusetts federal court on Friday to force the drugmaker to hand over documents from two patent suits involving Delzicol, saying the information is key to their antitrust claims.
- ← Previous
- 1
- 2
- 3
- Next →